UBL5 antibody
Principal name
UBL5 antibody
Alternative names for UBL5 antibody
Ubiquitin-like protein 5
Gene ID
59286 (UBL5)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of UBL5 antibody
Ubiquitin-like proteins (UBLs) are thought to be reversible modulators of protein function rather than protein degraders like ubiquitin (MIM 191339).[supplied by OMIM]. Transcript Variant: This variant (2) differs in the 5' UTR compared to variant 1. Both variants 1 and 2 encode the same protein.
General readings
Friedman JS. et al. (2001) Genomics 71:252-5.
McNally T. et al. (2003) Protein Sci. 12:1562-6.
Western Blot: UBL5 Lysate [NBL1-17555] - Western Blot experiments. Left-Control; Right -Over-expression Lysate for UBL5
Western Blot: UBL5 Lysate [NBL1-17556] - Western Blot experiments. Left-Control; Right -Over-expression Lysate for UBL5
Recombinant human UBL5, 1-73aa, His-tagged
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| H00059286-A01 | UBL5 antibody |
||||||
 |
Mouse | Serum | Hu | E, WB |
50 µl /
€290.00
|
||
| Abnova Taiwan Corp. | |||||||
| H00059286-M01 | UBL5 antibody |
||||||
|
Mouse | IgG1 | 2F7 | Purified | Hu | E, WB |
0.1 mg /
€370.00
|
| Abnova Taiwan Corp. | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302790 | UBL5 |
||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| TP311076 | UBL5 |
||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€680.00
|
|
| OriGene Technologies, Inc. | |||||
| AR39022PU-L | UBL5 (1-73, His-tag) |
||||
 |
Human | Purified | > 90 % | E. coli |
0.5 mg /
€1,000.00
|
| Acris Antibodies GmbH | |||||
 +1 additional image |
|||||
| AR39022PU-N | UBL5 (1-73, His-tag) |
||||
|
Human | Purified | > 90 % | E. coli |
0.1 mg /
€370.00
|
| Acris Antibodies GmbH | |||||
| +1 additional image |
|||||
| H00059286-P01-10 | UBL5 |
||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. |
10 µg /
€380.00
|
|
| Abnova Taiwan Corp. | |||||
| H00059286-P01-25 | UBL5 |
||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. |
25 µg /
€510.00
|
|
| Abnova Taiwan Corp. | |||||
| H00059286-Q01-10 | UBL5 |
||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. |
10 µg /
€380.00
|
|
| Abnova Taiwan Corp. | |||||
| H00059286-Q01-25 | UBL5 |
||||
|
Human | 12.5% SDS-PAGE Stained with Coomassie Blue. | in vitro transl. |
25 µg /
€510.00
|
|
| Abnova Taiwan Corp. | |||||
